Troglitazone

Troglitazone is a medication used to treat type 2 diabetes. It belongs to a class of drugs called thiazolidinediones (TZDs). Troglitazone works by increasing the body's sensitivity to insulin, which helps keep blood sugar levels in the normal range. It may also help reduce cholesterol levels in some people. Troglitazone is usually taken twice daily with meals. Common side effects include headache, nausea, and dizziness.

Troglitazone was a medication used to treat type 2 diabetes, but it is no longer prescribed due to the risk of serious side effects. Here's a breakdown of its history and why it's not used anymore:

Function:

• Belonged to a class of drugs called thiazolidinediones (TZDs).
• Worked by improving insulin sensitivity, helping the body use insulin more effectively to regulate blood sugar levels.

Past Use for Type 2 Diabetes:

• Offered some benefits in managing blood sugar, but other medications with a better safety profile emerged.

Reason for Withdrawal:

• Troglitazone was withdrawn from the market due to an increased risk of severe liver damage, including liver failure, in some patients.

Current Alternatives:

• Several other medications for type 2 diabetes are available with a lower risk of severe side effects. These include:
  • Metformin
  • Sulfonylureas
  • DPP-4 inhibitors
  • SGLT2 inhibitors